Breaking the Cycle of Inflammation in Parkinson’s Disease 7/15/2024
5 Neuro Data Readouts to Watch in the Second Half of 2024 7/15/2024
SignalChem Biotech, World Leader in Kinases, Is Now Part of Sino Biological 7/15/2024
Opinion: Congress Must Reauthorize FDA Program for Pediatric Rare Diseases 7/15/2024
Boehringer, Zealand Heat Up MASH Race With Strong Phase II Data 6/7/2024
FDA Raises Concerns About Lilly’s Donanemab Alzheimer’s Candidate Ahead of Adcomm 6/7/2024
FDA Approves Geron’s First-in-Class Telomerase Inhibitor for Blood Disorder 6/7/2024
Biomea’s Stock Nosedives More Than 60% as FDA Puts Clinical Hold on Diabetes Candidate 6/7/2024
MASH Clash Between Lilly and Boehringer-Zealand Takes Center Stage at EASL24 6/7/2024